Pilot Study of Autologous T-cells in Patients With Metastatic Pancreatic Cancer

NCT02465983 · clinicaltrials.gov ↗

PHASE1

Phase

TERMINATED

Status

4

Enrollment

OTHER

Sponsor class

Stopped Lack of efficacy and funding to continue investigation

Conditions

Pancreatic Cancer

Interventions

BIOLOGICAL: CART-meso-19 T cells
DRUG: Cyclophosphamide

Sponsor

University of Pennsylvania

Collaborators

[object Object]